Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. NC3235646

MALIX LLC The ViraDx™ SARS-CoV-2/Flu A+B Rapid Antigen Test detects and differentiates SARS-CoV-2, influenza A, and influenza B using nasal or nasopharyngeal swabs. Provides accurate results in 15 minutes. For in vitro diagnostic use, Rx only.

Supplier:  MALIX LLC VIRADXCOVFLU

Encompass

ViraDx™ POC Test for SARS-CoV-2, Flu A & B
The ViraDx™ SARS-CoV-2/Flu A+B Rapid Antigen Test is a lateral flow immunoassay designed for in vitro rapid, simultaneous qualitative detection and differentiation of nucleocapsid antigens from SARS-CoV-2, influenza A, and influenza B. It uses anterior nasal or nasopharyngeal swab specimens from patients suspected of COVID-19 by their healthcare provider within the first five days of symptom onset. This test provides efficient, rapid, and accurate results within 15 minutes, aiding in improved patient management decisions at the point-of-care. It is intended for in vitro diagnostic use and is for prescription use only (Rx).

Catalog No. NC3235646


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.